Mar 08, 2022 8:13am EST DiaMedica Therapeutics to Report Fourth Quarter 2021 Financial Results and Provide a Business Update March 15, 2022
Feb 02, 2022 8:43am EST DiaMedica Therapeutics Announces Appointment of Dominic Cundari as Chief Commercial Officer
Jan 25, 2022 8:43am EST DiaMedica Therapeutics to Present Research at International Stroke Conference
Dec 13, 2021 8:23am EST DiaMedica Therapeutics Announces Participation in LifeSci Partners 11th Annual Corporate Access Event
Nov 17, 2021 8:23am EST DiaMedica Therapeutics to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference
Nov 10, 2021 4:35pm EST DiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2021 Financial Results
Nov 09, 2021 4:07pm EST DiaMedica Therapeutics to Attend the 12th Annual Craig-Hallum Alpha Select Conference November 16, 2021
Nov 08, 2021 8:35am EST DiaMedica Therapeutics Announces Addition of Stroke Recurrence as a Second Independent Primary Endpoint in ReMEDy2 Phase 2/3 AIS Trial
Nov 04, 2021 8:30am EDT DiaMedica Therapeutics to Report Third Quarter 2021 Financial Results and Provide a Business Update November 11, 2021
